On 02 April 2020, DURECT Corporation (NASDAQ: DRRX) stock identified change of 186.00% away from 52-week low price and recently located move of -63.79% off 52-week high price. DRRX stock has been recorded -18.23% away from 50 day moving average and -16.61% away from 200 day moving average. Moving closer, we can see that shares have been trading -2.81% off 20-day moving average.
DURECT Corporation (DRRX) recently reported financial results for the three months and year ended December 31, 2019 and provided a corporate update.
Total revenues were $10.7M and net loss was $4.2M for the three months ended December 31, 2019 as contrast to total revenues of $3.6M and net loss of $7.3M for the three months ended December 31, 2018.
Total revenues were $29.6M and net loss was $20.6M for the year ended December 31, 2019, contrast to total revenues of $18.6M and net loss of $25.3M for the year ended December 31, 2018.
At December 31, 2019, cash and investments were $64.8M, contrast to cash and investments of $34.5M at December 31, 2018. Debt at December 31, 2019 was $20.3M, contrast to $20.5M at December 31, 2018.
“The highlight of the year for DURECT in 2019 was achieving positive results from our DUR-928 Phase 2a alcoholic hepatitis (AH) study, which were featured in multiple presentations at the Liver Meeting® 2019, including a late-breaking oral presentation by Dr. Tarek Hassanein,” stated James E. Brown, D.V.M., President and CEO of DURECT. “In addition, we have already exceeded our 60 patient enrollment target in the ongoing NASH trial, and the last patient is plannedto start the 28-day dosing period next week. We are on track to announce top-line NASH data mid-year. We are also making steady progress toward starting a Phase 2b AH clinical trial by mid-year. In January 2020, the FDA held an Advisory Committee meeting to discuss our POSIMIR NDA resubmission. Subsequently, we have continued to interact with FDA as they continue their review.”
DURECT Corporation noticed change of -7.14% to $1.43 along volume of 572912 shares in recent session compared to an average volume of 1461.86K. DRRX’s shares are at -62.37% for the quarter and driving a 130.13% return over the course of the past year and is now at -62.37% since this point in 2018. The average volatility for the week at 13.53% and for month was at 16.37%. There are 193.35M shares outstanding and 189.35M shares are floated in market.